Differents Laser Applications on Plantar Fasciitis (FASLaser)

December 26, 2025 updated by: Aurora Castro Mendez, University of Seville

Effects of Differents Laser Applications on Plantar Fasciitis

The objective of this randomized controlled clinical trial (RCT) with a double-blind technique and longitudinal chronology, is to evaluate and compare the effectiveness of High intensity laser therapy (HILT) in static mode versus scanning mode in the reduction of pain associated with plantar fasciitis.

The main questions it seeks to answer are:

  • What is the comparative effectiveness between low-level laser therapy in local spot mode and sweep mode in reducing pain in patients with plantar fasciitis?
  • What are the optimal therapeutic parameters (session duration, frequency and power) for LLLT in both modes, maximizing pain reduction in patients with plantar fasciitis?

Participants in this study will perform the following tasks:

  • Undergo HILT sessions or scanning mode.
  • Comply with the instructions on the duration and frequency of the sessions.
  • Record the pain levels experienced before and after each session.

The investigators will compare the group this differents laser to evaluate whether there are significant differences in pain reduction effects.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This randomized controlled clinical trial, titled 'Effect of Different Laser Applications on Plantar Fasciitis', aims to specifically address the effectiveness of static mode versus scanning mode (HILT) in the treatment of pain associated with plantar fasciitis. Using a rigorous methodology that includes double-blind masking and a longitudinal chronology, the study focuses on comparing two modes of laser application.

The main objective is to evaluate and compare the pain reduction between these two modes of application of LLLT. To achieve this, key questions are asked, such as the relative effectiveness of each mode and the identification of optimal therapeutic parameters, including session duration, frequency and power, that maximize benefits in patients with plantar fasciitis.

Participants in this study will undergo low-level laser therapy sessions, following the protocols established for each mode of application. Additionally, they will be asked to record their pain levels before and after each session, providing valuable information about the effectiveness of the therapy.

In the case of a comparison group, a detailed evaluation will be carried out comparing the results obtained between the group treated with static in local spot mode and the group treated in scanning mode. This approach will allow researchers to determine if there are significant differences in the pain reduction effects between the two modes of laser application.

With a solid experimental design and specific objectives, this study seeks to contribute significantly to the understanding of laser applications in the treatment of plantar fasciitis, providing valuable information for the optimization of therapy and thus improving the quality of life of patients. . affected.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Seville, Spain, 41009
        • Fasciitis
    • Andalusia
      • Seville, Andalusia, Spain, 41004
        • Área Clínica de Podología

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Study Population

subjects who present plantar fasciitis and go to the podiatry clinic within the indicated period

Description

Inclusion Criteria:

  • Confirmed Diagnosis of Plantar Fasciitis (at least 8 weeks), adults,

Exclusion Criteria:

  • Additional Serious Medical Conditions, Not receiving treatment at the time of the study for plantar fasciitis, neither, serious disease, a score of >3 on the DN4 questionnaire neuropathic pain, neither Pregnancy or lactation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: HILT Static mode
Hilt Scanning mode
Other: Static therapy
The intervention involves the precise and focused application of HILT on specific areas related to plantar fasciitis. The static mode technique is characterized by directing the laser directly to the painful point, seeking optimal stimulation in the affected region.The Scanning Mode technique is characterized by applying the HILT through a continuous, sweeping movement of the handpiece over the target area
Active Comparator: Shower laser application
laser application in shower or sweep mode
Other: Static Mode

The Scanning Mode technique is characterized by applying the HILT through a continuous, sweeping movement of the handpiece over the target area (the plantar fascia and adjacent tender regions).

This application ensures a more uniform energy distribution across a larger tissue area, potentially addressing inflammation and pain in a broader region than the static mode. The total dose is distributed over the area treated with a continuous motion.

Other Names:
  • Sweeping laser therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual pain analogic scale
Time Frame: 1,2 and 4 months
Visual pain scale from 0 minimum (best) to 10 maximum (worse)
1,2 and 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ultrasound image of thickness
Time Frame: 1,2 and 4 months
fascia thickness measured by ultrasound from minumum of 3 (Best) to maximum of 6 mm (Worse)
1,2 and 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Seville

Investigators

  • Principal Investigator: Aurora Castro Mendez, PhD, University of Seville

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

September 23, 2024

Study Registration Dates

First Submitted

February 22, 2024

First Submitted That Met QC Criteria

March 8, 2024

First Posted (Actual)

March 12, 2024

Study Record Updates

Last Update Posted (Estimated)

January 2, 2026

Last Update Submitted That Met QC Criteria

December 26, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 30923-N

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fasciitis, Plantar

Clinical Trials on Static therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe